Breakthrough in Alzheimer’s Treatment: Lomecel-B™ Receives RMAT Designation from FDA
Longeveron Inc., a clinical stage regenerative medicine biotechnology company, has achieved a significant milestone in the fight against Alzheimer’s Disease. The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to Lomecel-B™ for the treatment of mild Alzheimer’s Disease. This designation underscores the potential of Lomecel-B™ to provide a new […]
Revolutionizing Neurodegenerative Disease Treatment with Pluripotent Stem Cells: Insights from Sana Biotechnology
In an exciting development for the field of stem cell research, Sana Biotechnology has unveiled promising preclinical data in the prestigious journal, Nature Biotechnology. This data underscores the potential of pluripotent stem cell-derived human glial progenitor cells (hGPCs) in treating neurodegenerative diseases. Sana Biotechnology’s innovative approach focuses on harnessing the power of pluripotent stem cells, […]
Unlocking the Secrets of the Universe to Combat Neurodegenerative Diseases: NASA’s SpaceX CRS-30 Mission
In an unprecedented move towards understanding and potentially halting the progression of neurodegenerative diseases, NASA’s SpaceX CRS-30 Mission, in collaboration with the National Stem Cell Foundation, is set to launch its 6th investigation into the mysteries of these conditions. This mission marks a significant step forward in the fight against debilitating diseases like Alzheimer’s, Parkinson’s […]
Pioneering Neurodegenerative Disease Research with Stem Cell-Derived Brain Organoids in Space
The Groundbreaking Mission: In a significant leap towards understanding neurodegenerative disorders, the International Space Station National Lab is hosting an innovative research project. This project involves stem cell-derived brain organoids being sent to space as part of Axiom Space’s third private astronaut mission. The objective is to improve the modeling of diseases like Parkinson’s disease […]
Unlocking the Regenerative Potential of Stem Cell Therapy in Combating Alzheimer’s Disease
Welcome to a journey through the fascinating world of stem cell therapy and its potential in the fight against Alzheimer’s Disease (AD). This article isn’t just for scientists and medical professionals; it’s for anyone intrigued by the incredible advances in medical science and how they might one day revolutionize the treatment of neurodegenerative diseases like […]
Embryonic Stem Cell Research for Neurodegenerative Diseases
In the realm of medical science, few topics have sparked as much hope and controversy as stem cell therapy. These remarkable cells, with their unique ability to transform into various cell types, are a cornerstone of regenerative medicine. Among them, embryonic stem cells (ESCs) stand out due to their exceptional pluripotency. This article delves into […]
NurOwn: Revolutionizing ALS Treatment with Biomarkers
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, has presented new biomarker data from the Phase 3 trial of its late-stage investigational ALS treatment, NurOwn, at the 2023 ALS and Related Motor Neuron Diseases Gordon Research Conference. The data showed that treatment with NurOwn significantly elevated markers of […]
Unlocking the Brain’s Secret Weapon: The Power of Neural Stem Cells!
The Therapeutic Potential of Neural Stem Cells Imagine a construction site. The workers there are like cells in our body, each with a specific job to do. But among them, there are a few who are like the site managers, capable of taking on any role as needed. These are the stem cells, the body’s […]
Stem Cells in Space: The Unexpected Solution to Age-Related Diseases?
Age-related diseases like stroke, cancer, dementia, and other neurodegenerative conditions present significant challenges to patients and families, and pose an escalating health burden in the United States. Stem cell-based therapies may provide a solution, but creating large numbers of stem cells is challenging. To address this, scientists in regenerative medicine are using the International Space […]
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn®
NEW YORK, Dec. 27, 2022 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to discuss the contents of a refusal to file letter previously issued regarding the company’s New Biologics License Application […]